203 related articles for article (PubMed ID: 18046865)
1. Cost-effectiveness of smoking cessation and the implications for COPD.
Faulkner MA; Lenz TL; Stading JA
Int J Chron Obstruct Pulmon Dis; 2006; 1(3):279-87. PubMed ID: 18046865
[TBL] [Abstract][Full Text] [Related]
2. Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease.
Atsou K; Chouaid C; Hejblum G
PLoS One; 2011; 6(9):e24870. PubMed ID: 21949774
[TBL] [Abstract][Full Text] [Related]
3. Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.
Cadier B; Durand-Zaleski I; Thomas D; Chevreul K
PLoS One; 2016; 11(2):e0148750. PubMed ID: 26909802
[TBL] [Abstract][Full Text] [Related]
4. [Tobacco smoking cessation as covered cost for COPD patients? Therapy goal: smoking cessation without relapse].
Gross H
MMW Fortschr Med; 2010 Dec; 152(49-50):12-3. PubMed ID: 21302377
[No Abstract] [Full Text] [Related]
5. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.
Chen YF; Madan J; Welton N; Yahaya I; Aveyard P; Bauld L; Wang D; Fry-Smith A; Munafò MR
Health Technol Assess; 2012; 16(38):1-205, iii-v. PubMed ID: 23046909
[TBL] [Abstract][Full Text] [Related]
6. A lifetime Markov model for the economic evaluation of chronic obstructive pulmonary disease.
Menn P; Leidl R; Holle R
Pharmacoeconomics; 2012 Sep; 30(9):825-40. PubMed ID: 22799876
[TBL] [Abstract][Full Text] [Related]
7. A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease.
Lock K; Wilson K; Murphy D; Riesco JA
Expert Opin Pharmacother; 2011 Dec; 12(17):2613-26. PubMed ID: 22017336
[TBL] [Abstract][Full Text] [Related]
8. Healthcare financing systems for increasing the use of tobacco dependence treatment.
van den Brand FA; Nagelhout GE; Reda AA; Winkens B; Evers SMAA; Kotz D; van Schayck OC
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD004305. PubMed ID: 28898403
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of an intensive smoking cessation intervention for COPD outpatients.
Christenhusz LC; Prenger R; Pieterse ME; Seydel ER; van der Palen J
Nicotine Tob Res; 2012 Jun; 14(6):657-63. PubMed ID: 22180589
[TBL] [Abstract][Full Text] [Related]
10. Budgetary Impact Analysis of Reimbursement Varenicline for the Smoking-Cessation Treatment in Patients with Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease or Type-2 Diabetes Mellitus: A National Health System Perspective.
Cedillo S; Sicras-Mainar A; Jiménez-Ruiz CA; Fernández de Bobadilla J; Rejas-Gutiérrez J
Eur Addict Res; 2017; 23(1):7-18. PubMed ID: 27794567
[TBL] [Abstract][Full Text] [Related]
11. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization.
Curry SJ; Grothaus LC; McAfee T; Pabiniak C
N Engl J Med; 1998 Sep; 339(10):673-9. PubMed ID: 9725926
[TBL] [Abstract][Full Text] [Related]
12. Motivational Interviewing to Encourage Quit Attempts Among Smokers Not Ready to Quit: A Trial-Based Economic Analysis.
Rasu RS; Thelen J; Agbor Bawa W; Goggin K; Bradley-Ewing A; Catley D
Nicotine Tob Res; 2020 Aug; 22(9):1515-1523. PubMed ID: 31820002
[TBL] [Abstract][Full Text] [Related]
13. Cessation in the use of tobacco - pharmacologic and non-pharmacologic routines in patients.
Quist-Paulsen P
Clin Respir J; 2008 Jan; 2(1):4-10. PubMed ID: 20298298
[TBL] [Abstract][Full Text] [Related]
14. Smoking cessation for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis.
Thabane M;
Ont Health Technol Assess Ser; 2012; 12(4):1-50. PubMed ID: 23074432
[TBL] [Abstract][Full Text] [Related]
15. Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD.
Hoogendoorn M; Feenstra TL; Hoogenveen RT; Rutten-van Mölken MP
Thorax; 2010 Aug; 65(8):711-8. PubMed ID: 20685746
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands.
Tsiachristas A; Burgers L; Rutten-van Mölken MP
Value Health; 2015 Dec; 18(8):977-86. PubMed ID: 26686781
[TBL] [Abstract][Full Text] [Related]
17. A cost-effectiveness analysis of national smoking cessation services among chronic obstructive pulmonary disease patients in Thailand.
Prasitwarachot R; Thavorn K; Patikorn C; Wattanasirichaigoon S; Rungruanghiranya S; Thongphiew A; Chaiyakunapruk N
J Med Econ; 2023; 26(1):1377-1385. PubMed ID: 37818930
[TBL] [Abstract][Full Text] [Related]
18. The effect of quitting smoking on costs and healthcare utilization in patients with chronic obstructive pulmonary disease: a comparison of current smokers versus ex-smokers in routine clinical practice.
Sicras-Mainar A; Rejas-Gutiérrez J; Navarro-Artieda R; Ibáñez-Nolla J
Lung; 2014 Aug; 192(4):505-18. PubMed ID: 24816902
[TBL] [Abstract][Full Text] [Related]
19. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
[TBL] [Abstract][Full Text] [Related]
20. Study of Patients' Willingness to Pay for a Cure of Chronic Obstructive Pulmonary Disease in Taiwan.
Chen YT; Ying YH; Chang K; Hsieh YH
Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26938547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
